Menstrual‐related fluctuations in Parkinson's disease
The DOI matches its Crossref record.
Abstract
Eleven of 12 premenopausal women with idiopathic Parkinson's disease recognised an increased severity of their symptoms for a few days before and during menstruation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 10
- 10.1212/WNL.32.5.547 · DOI
- 10.1212/WNL.34.3.404 · doi:10.1212/wnl.34.3.404
- Fahn S, 1979, Post‐hypoxic action myoclonus: review of the literature and report of two new cases with response to valproate and estrogen, Adv Neurol, 26, 49
- 10.1016/S0140-6736(66)90638-6 · doi:10.1016/s0140-6736(66)90638-6
- 10.1001/archneur.1966.00470180027003 · doi:10.1001/archneur.1966.00470180027003
- Quinn NP, 1984, Dominantly inherited myoclonic dystonia with dramatic response to alcohol, Neurology (Cleveland), 34, 236
- 10.1097/00002826-198503000-00010 · doi:10.1097/00002826-198503000-00010
- Bedard P, 1979, Estrogens, progesterone, and the extrapyramidal system, Adv Neurol, 24, 411
- Magos A, 1985, Effects of the menstrual cycle on medical disorders, Br J Hosp Med, 33, 68
- 10.1017/S0033291700020870 · DOI
Cited by
Gillies, G. E., & McArthur, S. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002071 · Cited by 733
“For example, at the onset of menses and menopause, and after withdrawal of hormone replacement therapy, when endogenous estrogen levels are low, parkinsonian symptoms worsen (Quinn and Marsden, 1986; Sandyk, 1989).”
BackgroundSex differences in Parkinson’s disease
Gillies, G. E., Pienaar, I. S., Vohra, S., & Qamhawi, Z. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.02.002 · Cited by 489
Estrogens, Neuroinflammation, and Neurodegeneration
Villa, A., Vegeto, E., Poletti, A., & Maggi, A. (2016) · Endocrine Reviews · doi:10.1210/er.2016-1007 · Cited by 423
Estrogen–BDNF interactions: Implications for neurodegenerative diseases
Sohrabji, F., & Lewis, D. K. (2006) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2006.09.003 · Cited by 287
The effect of estrogen replacement on early Parkinson’s disease
Saunders-Pullman, R., Gordon-Elliott, J., Parides, M., Fahn, S., Saunders, H. R., & Bressman, S. (1999) · Neurology · doi:10.1212/wnl.52.7.1417 · Cited by 270
Caffeine, postmenopausal estrogen, and risk of Parkinson’s disease
Ascherio, A., Chen, H., Schwarzschild, M. A., Zhang, S. M., Colditz, G. A., & Speizer, F. E. (2003) · Neurology · doi:10.1212/01.wnl.0000046523.05125.87 · Cited by 234
Sex differences in movement disorders
Meoni, S., Macerollo, A., & Moro, E. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-019-0294-x · Cited by 207
Sex: A Significant Risk Factor for Neurodevelopmental and Neurodegenerative Disorders
Pinares-Garcia, P., Stratikopoulos, M., Zagato, A., Loke, H., & Lee, J. (2018) · Brain Sciences · doi:10.3390/brainsci8080154 · Cited by 200
“Similarly, symptoms worsen in female PD or MS patients with the onset of menopause or before the onset of menses during the menstrual cycle [229,230].”
BackgroundMurray, H. E., Pillai, A. V., McArthur, S. R., Razvi, N., Datla, K. P., Dexter, D. T., & Gillies, G. E. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00578-x · Cited by 189
“, 2000) and there is a marked worsening of parkinsonian symptoms following withdrawal of hormone replacement therapy in postmenopausal women (Sandyk, 1989) as well as at times of the menstrual cycle when estrogen levels are low (Quinn and Marsden, 1986).”
BackgroundMale/female differences in neuroprotection and neuromodulation of brain dopamine
Bourque, M. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00035 · Cited by 40
“A reduction in levodopa effectiveness was also observed before and during the menstruation period in young PD women (Quinn and Marsden, 1986; Giladi and Honigman, 1995).”
Background
Metadata
- Authors
- Quinn, N. P., & Marsden, C. D.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 1986-01
- Volume
- 1
- Issue
- 1
- Pages
- 85-87
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2094789951
- Cited by
- 124
- References
- 0
- FWCI
- 2.16
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.